NPI: 1174586192 · LOS ANGELES, CA 90017 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 04/10/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 04/10/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 23,630 | $4.12M |
| 2019 | 14,788 | $1.06M |
| 2020 | 17,631 | $1.01M |
| 2021 | 14,451 | $667K |
| 2022 | 9,652 | $1.22M |
| 2023 | 14,496 | $1.94M |
| 2024 | 13,550 | $1.55M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 59,115 | 5,252 | $8.09M |
| 0821 | 1,264 | 680 | $2.41M | |
| 90945 | 4,889 | 327 | $532K | |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 16,001 | 2,206 | $358K |
| J1270 | Injection, doxercalciferol, 1 mcg | 6,656 | 1,068 | $66K |
| J1756 | Injection, iron sucrose, 1 mg | 5,405 | 2,058 | $55K |
| A4657 | Syringe, with or without needle, each | 3,545 | 2,007 | $32K |
| 0250 | 1,407 | 161 | $9K | |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 737 | 483 | $6K |
| 83970 | 1,512 | 1,459 | $6K | |
| 82728 | 1,199 | 1,143 | $4K | |
| 83550 | 1,027 | 970 | $2K | |
| 82570 | 49 | 27 | $2K | |
| 85048 | 1,716 | 1,621 | $2K | |
| 83540 | 1,212 | 1,143 | $1K | |
| 85041 | 1,713 | 1,623 | $1K | |
| 90674 | 107 | 104 | $1K | |
| 0302 | 369 | 267 | $72.88 | |
| 90662 | 86 | 85 | $32.32 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 119 | 65 | $7.39 |
| G0008 | Administration of influenza virus vaccine | 70 | 67 | $4.90 |